Purpose: The purpose of this study is to characterize intraday and interday variation in central corneal thickness (CCT) in healthy and glaucomatous subjects.
I
t has been well established that central corneal thickness (CCT) is an independent risk factor for the progression from ocular hypertension to open-angle glaucoma. 1, 2 Further studies have indicated that CCT is linked to glaucoma risk and glaucoma progression. [3] [4] [5] [6] [7] [8] Because CCT is utilized in global risk assessment of both suspected and established glaucoma, accurate assessment of CCT values is fundamentally important in the management of patients with ocular hypertension as well as glaucoma.
The consistency of CCT measurements over time has not been established, and some data suggest that significant intervisit variation in CCT measurement exists. 9, 10 The purpose of this study was to characterize the intraday and interday variability of CCT in eyes with and without open-angle glaucoma.
METHODS
This was a post hoc analysis of data collected during the Diurnal Intraocular Pressure (IOP) Variability Assessment study. This study was approved by the institutional review board at West Virginia University, and all subjects provided written informed consent to participate. Participating subjects were either healthy subjects or had primary open-angle glaucoma (POAG). For the purposes of enrollment, patients with POAG had glaucomatous optic discs and repeatable visual field loss. A glaucomatous optic disc was defined as having evidence of excavation, diffuse or focal thinning or notching of the neuroretinal rim, visible nerve fiber layer defects, or asymmetry of the vertical cupdisc ratio of > 0.2 between eyes. An abnormal visual field was defined as having a pattern standard deviation outside the 95% normal limits for Swedish Interactive Threshold Algorithm fields, or a corrected pattern standard deviation outside the 95% normal limits for Humphrey Full Threshold algorithm tests, or an abnormal glaucoma hemifield test using either test strategy. Visual field loss was reproducible over at least 2 consecutive visual field tests. Subjects with POAG were eligible if they were using identical therapy in both eyes (topical eye drop medications and/or bilateral laser trabeculoplasty); POAG subjects on topical therapy remained on unchanged therapy during their participation in this study. Healthy subjects had IOP of 21 mm Hg or less (and no history of IOP above 21 mm Hg), open angles, normal-appearing optic discs, normal visual fields, and no family history of glaucoma. Healthy subjects were excluded if they had another ocular condition that might affect IOP or corneal pathology that might limit the value of tonometry or pachymetry readings.
All subjects attended 5 visits at baseline and 1 week, 1 month, 6 months, and 1 year after baseline. At each visit, IOP was measured using Goldmann tonometry (Haag Streit, Mason, OH) at 2-hour intervals from 08:00 to 20:00. CCT was assessed immediately following the 08:00 IOP measurement on each of the 5 days (interday measurements), and immediately following IOP measurement at each diurnal time point on 1 of the 5 days (intraday measurements). CCT was measured in the seated position using the DGH Pachette 2 ultrasound pachymeter (DGH Technology, Exton, PA). Right eyes were measured before left eyes, and each measurement represented the average of 5 values taken from different regions of the central cornea overlying the pupil. All subjects underwent assessment by the same examiner using the same pachymeter at all visits and time points.
The primary objective of this study was to characterize the magnitude of intraday and interday CCT variation and to compare the 2. Descriptive statistics were generated to characterize mean CCT at each visit and time point by group. Mean age and gender/race distribution were examined and compared between healthy and POAG subjects by a t test and χ 2 tests, respectively. Linear mixed models were utilized to estimate between-subject (σ b 2 ) and within-subject variances (σ w 2 ) of both intraday and interday CCT measurements, calculated separately for healthy subjects and glaucoma patients. Various correlation models were initially examined and the resulting Akaike Information Criteria (AIC) values compared with verify that the assumption of a constant correlation across time points was appropriate. Intraclass correlation coefficients (ICCs; ICC = σ b 2 /(σ b 2 +σ w 2 )) were calculated for both interday and intraday measurements, separately for healthy and POAG patients. Testing the hypothesis that mean intraday CCT variation and mean interday CCT variation were comparable was accomplished using a likelihood-ratio test of equality of within-subject variance between intraday and interday CCT measurements. The ICC is a type of correlation that can be used to describe the degree of relatedness between measurements; the closer the ICC is to 1, the less within-subject variability relative to the between-subject variability. ICC (3,1) was utilized to describe a random set of subjects and a fixed set of time points. A total of 1000 bootstrap samples were generated to establish 95% confidence intervals for the ICC's. Only data from right eyes were included in this analysis.
RESULTS
Participants were 40 healthy people and 42 people with POAG. Demographic information is given in Table 1 . Overall, the mean age of participants was 66.3 ± 11.9 years, 95% were white and 66% were women. Healthy participants and glaucoma patients were demographically similar (Table 1) . Glaucoma patients used an average of 1.4 topical medications for IOP control.
Mean CCT values at each of the 5 visits and at each of the 7 diurnal time points are given in Table 2 . CCT values in healthy subjects were consistently numerically higher than for subjects with glaucoma. Only CCT at 1000 and at the month-6 visit were statistically significantly different between healthy and glaucomatous participants at the 0.05 level, but the significance of these findings was marginal (P = 0.036 and P = 0.027, respectively).
Mean CCT did not vary significantly throughout the 12-hour diurnal period in either healthy subjects (P = 0.059) nor glaucoma patients (P = 0.696). Interday mean CCT did vary significantly in both healthy subjects (P = 0.0001) and glaucoma patients (P = 0.005), with CCT generally increasing over time.
Within subjects, there was substantial intraday and interday variation of CCT measurements. The mean range of intraday CCT measurements (highest minus lowest of 7 intraday measurements) was 21 ± 10 µm in healthy subjects and 21 ± 10 µm in glaucoma patients. These intraday CCT differences were statistically significantly different from 0 (P < 0.0001) in both groups. The distribution of intraday CCT differences of both healthy subjects and glaucoma patients is given in Fig. 1 . Among healthy participants, 12.5% of eyes manifested an intraday CCT difference of 30 µm or more; among glaucomatous participants, 11.9% of eyes did so.
Likewise, there was substantial within-subject interday and interday variation of CCT measurements. The mean range of interday CCT measurements (highest minus lowest of 5 interday measurements) was 27 ± 13 µm in healthy subjects and 26 ± 18 µm in glaucoma patients. These interday CCT differences were statistically significantly different from 0 (P < 0.0001) in both groups and their distributions in both healthy subjects and glaucoma patients is given in Fig. 2 . Among healthy participants, 27.5% of eyes manifested an interday CCT difference of ≥ 30 µm; among glaucomatous participants, 30.9% of eyes did so.
Variance component estimates and comparisons are given in Table 3 . The ICCs revealed excellent agreement for both intraday and interday CCT measurements in both healthy subjects and glaucoma patients, although interday ICC values were numerically lower than intraday ICC values for both groups. Comparison of within-subject intraday versus interday variance demonstrated that CCT measurements taken 
on different days were significantly more variable than CCT measurements taken on the same day in both healthy subjects (P < 0.0001) and glaucoma patients (P < 0.0001).
DISCUSSION
Accurate and reproducible intraday and interday assessment of CCT is necessary to perform global risk assessment of patients with suspected or established glaucoma. The current study demonstrates that CCT measurements vary substantially throughout the day and even more so from day to day. As a result, our data suggest that a single CCT measurement at one moment in time may inadequately characterize CCT. Approximately 30% of both healthy subjects and glaucoma patients exhibited differences in CCT measurements of 30 µm or more on different days.
A change in CCT of this magnitude has significant clinical impact on risk assessment in patients with suspected or known glaucomatous optic neuropathy. In the risk model based on the combined data from the Ocular Hypertension Treatment Study and European Glaucoma Treatment Study, CCT is the strongest predictor for converting from ocular hypertension to POAG. 11 Using the online risk calculator based upon this model (http://ohts.wustl.edu/risk/calculator.html) and a typical ocular hypertensive patient profile [age, 60 y; untreated IOP 26 mm Hg, vertical cup-disc ratio (VCDR) 0.4, Humphrey visual field pattern standard deviation (VFPSD) 0.5 dB], a 30-µm change in CCT from 575 to 545 (centered on the average CCT observed in this study of 560 µm) changes the 5-year risk of conversion to POAG from 4.5% to 7.6%, a 67% relative increase in risk. This has the consequence of altering the recommended management from "observe without treatment" to "consider treatment." 12 Song et al 13 demonstrated that longitudinal variability in CCT as well as IOP, VCDR, and VFPSD can alter POAG conversion risk estimates by nearly 10-fold (1000%) in ocular hypertensive individuals over time. In established POAG, a validated risk model for progression to worse glaucoma has also been described and includes CCT as a risk factor. 14 Using the online risk calculator based on this model (http://glaucoma.net/calculator/) and a typical early POAG patient profile (age, 60 y; mean untreated IOP, 26 mm Hg; peak treated IOP, 22 mm Hg; Humphrey visual field mean deviation, −4.5 dB; and no disc hemorrhage, peripapillary atrophy, pseudoexfoliation, or prior glaucoma surgery), a similar 30-µm change in CCT from 575 to 545 µm increases the 5-year risk of visual field progression from 9.5% to 12.2%, a 28% relative increase in risk.
The results of the current study indicate that interday CCT variation is greater than intraday variation. Previous studies have characterized intraday diurnal (day-time hours) and circadian (24-h) CCT variation (measured by ultrasonic pachymetry) in healthy subjects [15] [16] [17] [18] [19] [20] as well as in subjects with suspected 21 or established glaucoma. 20 In all of these studies, mean CCT values of the respective samples were compared across time points, precluding evaluation of CCT variation within individuals as reported in the current study. Studies evaluating diurnal CCT variation have reported no significant changes throughout the day in eyes of healthy subjects [18] [19] [20] or subjects with suspected glaucoma, 21 but 1 study revealed a small but significant 12 µm increase in CCT between 09:00 and 17:00 hours in glaucomatous eyes. 20 In contrast, our data demonstrated that both healthy and glaucomatous eyes manifested an average CCT variation of 21 µm over a 12-hour period, with approximately 12% of eyes manifesting a 12-hour CCT variation in excess of 30 µm.
There are fewer data characterizing interday CCT variation measured by ultrasonic pachymetry. An evaluation of CCT in 20 healthy subjects on 2 days separated by a median of 12 days revealed a mean interday CCT variation of +1.2 ± 11.6 µm. 9 A study of 51 glaucoma patients or suspects reported mean CCT variation between 2 days separated by a mean of 84 days of 9.6 ± 26.9 µm in right eyes and 19.0 ± 29.2 µm in left eyes. 10 The Ocular Hypertension Treatment Study (OHTS) group reported data on longitudinal CCT assessment; among both treated and untreated ocular hypertensive individuals, the mean change in CCT over a 3.8-year period was −2.7 ± 13.4 μm. 22 Each of these 3 reports defined CCT variation as the difference between the 2 visits (visit 2 minus visit 1 as opposed to higher minus lower) so that values for CCT variation could be positive or negative. This explains why the mean is close to 0 in 2 of the studies, 9,22 but does not explain the bias toward significantly higher CCT values at the follow-up visit in the remaining study. 10 Interestingly, our data also revealed a trend toward higher CCT at later follow-up visits compared with baseline ( Table 2 and Fig. 1 ). The basis for this trend is unclear and is unlikely to represent a visit-dependent methodologic bias; subjects in the current study attended the 5 visits of this study in a series of 10 groups over a 2-year time period, and subjects on a given day often were attending different visits (eg, some were starting the study on the same day others were finishing).
This study is strengthened by several features of its design. All subjects were evaluated by the same study personnel using the same device throughout the study, minimizing errors attributable to interoperator or interdevice variation. Subjects were evaluated on 5 days over the course of a year, more often than any previously published report of which we are aware. All subjects were untreated or on stable medical regimens and none underwent any surgical procedures during the study period, thus reducing exogenous sources of CCT variation. However, the analysis was conducted post hoc on an existing data set. Although they were not collected specifically to investigate CCT variability over time, these data are suitable for such inquiry. Measurement of CCT after Goldmann tonometry may have affected CCT measurements. However, we followed the methodology of the Ocular Hypertension Treatment Study (in which ultrasound pachymetry was performed after Goldmann tonometry), and we prioritized Goldmann tonometry over CCT in our original data set because the primary outcome of interest was related to IOP. The lack of 24-hour data is also a limitation which precludes fuller characterization of intraday circadian CCT variation. One potential source of bias is our use of the maximum and minimum CCT values to determine CCT variability; this approach is susceptible to overestimation of CCT variation in the presence of outlying CCT values (which may have been selected as the maximum or minimum CCT value for calculating variability). CCT values at each time point were the mean of 5 separate readings. For a single outlying measurement to affect a CCT value (mean of 5 measurements) would require that it differ substantially from the other 4 measurements. Outliers such as these are typically recognized at the time of CCT measurement. Although there were no formal rules for identifying and dealing with outliers among these 5 measurements, it was our practice to discard such outliers that differ from the remaining 4 and collect an additional measurement to replace it. Another type of outlier can arise if all 5 measurements at a given time point are generally close to one another but differ substantially from values at other time points. It is unlikely that all 5 measurements at a given time point would be similarly erroneous; thus, these values were accepted as true representations of the CCT at that time point. Our handling of these outliers represents real-world handling of such data: if 1 of 5 measurements is suspect then replace it, but if all 5 are consistent with one another, then accept them. Finally, we cannot infer whether the intraday and interday CCT variation observed in our study arises because of true changes in CCT over time, limitations of reproducibility of the pachymetry device, variations in operator technique, or a combination of all 3. Because this study was not originally designed to evaluate CCT variability or factors associated with CCT variability, we have not conducted analyses to explore factors associated with CCT variability. Future studies should be specifically designed and adequately powered to test hypotheses related to factors that might be associated with CCT variability.
In summary, CCT measurement by ultrasonic pachymetry exhibited significant intraday and interday variation, with the latter being significantly greater in magnitude than the former. A single CCT assessment in time inadequately characterizes CCT. Interday CCT variation is great enough to significantly alter risk assessment of subjects with suspected or established glaucoma. We recommend a series of measurements on different days which provides better characterization of CCT and 
